Osaka, Japan

Yasuyo Tomishima


Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2002-2009

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Yasuyo Tomishima

Introduction

Yasuyo Tomishima is a notable inventor based in Osaka, Japan. With a remarkable portfolio of six patents, she has contributed significantly to the field of pharmaceuticals through her innovative research and formulations. Her work focuses on the development of compounds that hold potential therapeutic benefits.

Latest Patents

Among her latest inventions are aminoalcohol derivatives and propanolamine derivatives. The aminoalcohol derivatives relate to a compound formula designed to exhibit various biological activities. The propanolamine derivatives are new compounds or salts that have remarkable applications, including gut-selective sympathomimetic effects, anti-ulcerous properties, and activities against urinary incontinence and pollakiuria. These inventions include processes for preparing these compounds, pharmaceutical compositions comprising them, and methods for their application in treating diseases as described in the specifications.

Career Highlights

Yasuyo has made significant strides in her career, having worked for prominent pharmaceutical companies such as Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. Her experience and expertise have played a crucial role in her achievements as an inventor in the pharmaceutical landscape.

Collaborations

Throughout her career, Yasuyo has collaborated with distinguished colleagues, including Kiyoshi Taniguchi and Minoru Sakurai. These collaborations have aided in the advancement of her research and the successful development of her patented inventions.

Conclusion

Yasuyo Tomishima's innovative contributions in the realm of aminoalcohol and propanolamine derivatives underscore her importance as an inventor. With her continued research and development efforts, she is poised to make further significant impacts in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…